OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma—rationale for targeting ARID1A deficiency
Xiaochuan Dong, Shumei Song, Yuan Li, et al.
Gut (2021) Vol. 71, Iss. 3, pp. 467-478
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis
Yong Xiang Gwee, Daryl Kai Ann Chia, Jimmy Bok Yan So, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 24, pp. 2830-2830
Open Access | Times Cited: 58

Early stage gastric adenocarcinoma: clinical and molecular landscapes
Yuki Hirata, Ayesha Noorani, Shumei Song, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 453-469
Closed Access | Times Cited: 30

SOX9 Modulates the Transformation of Gastric Stem Cells Through Biased Symmetric Cell Division
Qi‐Yue Chen, Kai Weng, Mi Lin, et al.
Gastroenterology (2023) Vol. 164, Iss. 7, pp. 1119-1136.e12
Open Access | Times Cited: 24

Comprehensive molecular phenotyping ofARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities
Chang Xu, Kie Kyon Huang, Jia Hao Law, et al.
Gut (2023) Vol. 72, Iss. 9, pp. 1651-1663
Closed Access | Times Cited: 19

ARID1Amutations in cancer development: mechanism and therapy
Xuewei Zhang, Yixuan Zhang, Jinyi Zhao, et al.
Carcinogenesis (2023) Vol. 44, Iss. 3, pp. 197-208
Closed Access | Times Cited: 15

Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesis
Adrian Kwan Ho Loe, Lexin Zhu, Tae-Hee Kim
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 1, pp. 22-31
Open Access | Times Cited: 12

The Ubiquitin–Proteasome System in Tumor Metabolism
Jie Wang, Yuandi Xiang, Mengqi Fan, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2385-2385
Open Access | Times Cited: 12

A comprehensive analysis of molecular characteristics of hot and cold tumor of gastric cancer
Chenxi Lv, Tianwei Chen, Jiangtao Li, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access

Methionine and Leucine Promote mTOR Gene Transcription and Milk Synthesis in Mammary Epithelial Cells through the eEF1Bα-UBR5-ARID1A Signaling
Hao Qi, Mengmemg Yu, Xiuqiang Fan, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 20, pp. 11733-11745
Closed Access | Times Cited: 3

The effects of ARID1A mutation in gastric cancer and its significance for treatment
Shan Lü, Ruifeng Duan, Cong Liang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7

The Role of the AT-Rich Interaction Domain 1A Gene (ARID1A) in Human Carcinogenesis
Jing Jing Li, Cheok Soon Lee
Genes (2023) Vol. 15, Iss. 1, pp. 5-5
Open Access | Times Cited: 7

Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma
Shumei Song, Yan Xu, Longfei Huo, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 16

Advances in targeted therapy for gastric cancer based on tumor driver genes
Shiying Wu, Pinglong Xu, Fei Zhang
Journal of Zhejiang University (Medical Sciences) (2024) Vol. 53, Iss. 1, pp. 73-83
Open Access | Times Cited: 1

Rapamycin alleviates mitochondrial dysfunction in anti-NMDAR encephalitis mice
Liangbo Kong, Xiaxin Yang, Anqi Sun, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111910-111910
Closed Access | Times Cited: 1

The role of SWI/SNF complexes in digestive system neoplasms
Hanyun Liang, Xin Zheng, Xiao Zhang, et al.
Medical Oncology (2024) Vol. 41, Iss. 5
Closed Access | Times Cited: 1

GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
Yuan Li, Yibo Fan, Jinbang Xu, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 6

Next-generation sequencing identifies potential novel therapeutic targets in Chinese HGSOC patients
Junyan Tao, Dantong Sun, Hai Zhou, et al.
Pathology - Research and Practice (2022) Vol. 238, pp. 154074-154074
Closed Access | Times Cited: 5

ARID1A deficiency is targetable by AKT inhibitors in HER2-negative gastric cancer
Takahiro Sato, Motonobu Saito, Shotaro Nakajima, et al.
Gastric Cancer (2023) Vol. 26, Iss. 3, pp. 379-392
Open Access | Times Cited: 2

A mutational signature and ARID1A mutation associated with outcome in hepatocellular carcinoma
Wei Zhou, Hao Chi, Xiaohu Zhao, et al.
Clinical & Translational Oncology (2024) Vol. 27, Iss. 3, pp. 1166-1175
Closed Access

Targeting the alterations of ARID1A in pancreatic cancer: tumorigenesis, prediction of treatment, and prognostic value.
Ruichao Li, Guangbing Xiong, Jun Zhao, et al.
PubMed (2022) Vol. 14, Iss. 9, pp. 5952-5964
Closed Access | Times Cited: 2

Reply
Qiyue Chen, Kai Weng, Jianwen Que
Gastroenterology (2023) Vol. 165, Iss. 4, pp. 1095-1095
Closed Access

Magenkarzinome mit ARID1A-Mangel könnten auf mTOR-Inhibitoren ansprechen

Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 07, pp. 1085-1085
Closed Access

Page 1 - Next Page

Scroll to top